AU2002365931A1 - Hepatitis e virus clones and methods of their use - Google Patents

Hepatitis e virus clones and methods of their use

Info

Publication number
AU2002365931A1
AU2002365931A1 AU2002365931A AU2002365931A AU2002365931A1 AU 2002365931 A1 AU2002365931 A1 AU 2002365931A1 AU 2002365931 A AU2002365931 A AU 2002365931A AU 2002365931 A AU2002365931 A AU 2002365931A AU 2002365931 A1 AU2002365931 A1 AU 2002365931A1
Authority
AU
Australia
Prior art keywords
hepatitis
methods
virus clones
clones
virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002365931A
Inventor
Suzanne U. Emerson
Xiang-Jin Meng
Robert H. Purcell
Mingdong Zhang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GOVERNMENT OF United States, HEALT, Secretary of, Department of
Original Assignee
US Department of Health and Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Health and Human Services filed Critical US Department of Health and Human Services
Publication of AU2002365931A1 publication Critical patent/AU2002365931A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/28011—Hepeviridae
    • C12N2770/28111—Hepevirus, e.g. hepatitis E virus
    • C12N2770/28122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/28011—Hepeviridae
    • C12N2770/28111—Hepevirus, e.g. hepatitis E virus
    • C12N2770/28161—Methods of inactivation or attenuation
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/10—Screening for compounds of potential therapeutic value involving cells
AU2002365931A 2001-11-09 2002-11-08 Hepatitis e virus clones and methods of their use Abandoned AU2002365931A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US35012201P 2001-11-09 2001-11-09
US60/350,122 2001-11-09
PCT/US2002/036096 WO2003063679A2 (en) 2001-11-09 2002-11-08 Hepatitis e virus clones and methods of their use

Publications (1)

Publication Number Publication Date
AU2002365931A1 true AU2002365931A1 (en) 2003-09-02

Family

ID=27662977

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002365931A Abandoned AU2002365931A1 (en) 2001-11-09 2002-11-08 Hepatitis e virus clones and methods of their use

Country Status (2)

Country Link
AU (1) AU2002365931A1 (en)
WO (1) WO2003063679A2 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001057073A2 (en) * 2000-02-07 2001-08-09 Department Of Science And Technology Infectious cdna clone of hepatitis e virus (hev) genome, its production and uses

Also Published As

Publication number Publication date
WO2003063679A2 (en) 2003-08-07
WO2003063679A3 (en) 2003-12-04
WO2003063679A8 (en) 2004-12-23

Similar Documents

Publication Publication Date Title
AU2002361563A1 (en) Anti-tombstoning structures and methods of manufacture
ZA200305825B (en) Modified antibodies and methods of use
AU2002314466A1 (en) Withasol and methods of use
WO2003059257A8 (en) Anti-angiogenic proteins and fragmentsand methods of use thereof
AU2002306768A1 (en) Expression profiles and methods of use
AU2002259130A1 (en) Agents for treatment of hcv and methods of use
AU2002225954A1 (en) Dipeptidylpeptidases and methods of use
AU2002326751A1 (en) Immunoglobulin e vaccines and methods of use thereof
AU2003216523A1 (en) Treatment of pre-core hepatitis b virus mutant infections
IL162236A0 (en) Purified hepatitis c virus envelopeproteins for dagnostic and therapeutic use
HK1062579A1 (en) A fusion protein for treatment of hepatitis b virus and its use thereof
AU2002213346A1 (en) Osteopontin-coated surfaces and methods of use
AU2002324973A1 (en) Immunoglobulin having particular framework scaffold and methods of making and using
AU2001292667A1 (en) Immunogenic composition of hepatitis c and methods of use thereof
AU2002251999A1 (en) Methods and compositions for the construction and use of fusion libraries using computational protein design methods
AU2002363938A1 (en) Methods and use of motoneuronotropic factors
AU2002310237A1 (en) Sponge-derived terpenoids and methods of use
AU2001269092A1 (en) Inhibitors of hepatitis b virus infection
AU2002347464A1 (en) Anti-arthropod vector vaccines methods of selecting and uses thereof
AU2003301865A1 (en) Epitopes of hepatitis c virus
AU2002365931A1 (en) Hepatitis e virus clones and methods of their use
AU2003287216A1 (en) Gb virus c and methods of treating viral infections
AU2001234596A1 (en) Use of castanospermine and substituted-castanospermine compounds for treating hepatitis virus infections
AU2002355432A1 (en) Kavalactone compositions and methods of use
AU2001282560A1 (en) Methods of infection with hepatitis c virus

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase